365 related articles for article (PubMed ID: 21145788)
21. Germline MLH1, MSH2 and MSH6 variants in Brazilian patients with colorectal cancer and clinical features suggestive of Lynch Syndrome.
Schneider NB; Pastor T; Paula AE; Achatz MI; Santos ÂRD; Vianna FSL; Rosset C; Pinheiro M; Ashton-Prolla P; Moreira MÂM; Palmero EI;
Cancer Med; 2018 May; 7(5):2078-2088. PubMed ID: 29575718
[TBL] [Abstract][Full Text] [Related]
22. Mutation analysis of the MLH1, MSH2 and MSH6 genes in patients with double primary cancers of the colorectum and the endometrium: a population-based study in northern Sweden.
Cederquist K; Emanuelsson M; Göransson I; Holinski-Feder E; Müller-Koch Y; Golovleva I; Grönberg H
Int J Cancer; 2004 Apr; 109(3):370-6. PubMed ID: 14961575
[TBL] [Abstract][Full Text] [Related]
23. Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population.
Lagerstedt-Robinson K; Rohlin A; Aravidis C; Melin B; Nordling M; Stenmark-Askmalm M; Lindblom A; Nilbert M
Oncol Rep; 2016 Nov; 36(5):2823-2835. PubMed ID: 27601186
[TBL] [Abstract][Full Text] [Related]
24. Targeted Next-Generation Sequencing of
Özdemir TR; Alan M; Sancı M; Koç A
Balkan Med J; 2019 Jan; 36(1):37-42. PubMed ID: 30238922
[TBL] [Abstract][Full Text] [Related]
25. [A novel genetic disorder of Lynch syndrome - EPCAM gene deletion].
Tomita N; Yamano T; Matsubara N; Tamura K
Gan To Kagaku Ryoho; 2013 Feb; 40(2):143-7. PubMed ID: 23411950
[TBL] [Abstract][Full Text] [Related]
26. Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1.
Ligtenberg MJ; Kuiper RP; Chan TL; Goossens M; Hebeda KM; Voorendt M; Lee TY; Bodmer D; Hoenselaar E; Hendriks-Cornelissen SJ; Tsui WY; Kong CK; Brunner HG; van Kessel AG; Yuen ST; van Krieken JH; Leung SY; Hoogerbrugge N
Nat Genet; 2009 Jan; 41(1):112-7. PubMed ID: 19098912
[TBL] [Abstract][Full Text] [Related]
27. Lynch-like syndrome: characterization and comparison with EPCAM deletion carriers.
Kang SY; Park CK; Chang DK; Kim JW; Son HJ; Cho YB; Yun SH; Kim HC; Kwon M; Kim KM
Int J Cancer; 2015 Apr; 136(7):1568-78. PubMed ID: 25110875
[TBL] [Abstract][Full Text] [Related]
28. Phenotype comparison of MLH1 and MSH2 mutation carriers in a cohort of 1,914 individuals undergoing clinical genetic testing in the United States.
Kastrinos F; Stoffel EM; Balmaña J; Steyerberg EW; Mercado R; Syngal S
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2044-51. PubMed ID: 18708397
[TBL] [Abstract][Full Text] [Related]
29. Genetic and genomic basis of the mismatch repair system involved in Lynch syndrome.
Tamura K; Kaneda M; Futagawa M; Takeshita M; Kim S; Nakama M; Kawashita N; Tatsumi-Miyajima J
Int J Clin Oncol; 2019 Sep; 24(9):999-1011. PubMed ID: 31273487
[TBL] [Abstract][Full Text] [Related]
30. Screening for germline mutations of MLH1, MSH2, MSH6 and PMS2 genes in Slovenian colorectal cancer patients: implications for a population specific detection strategy of Lynch syndrome.
Berginc G; Bracko M; Ravnik-Glavac M; Glavac D
Fam Cancer; 2009; 8(4):421-9. PubMed ID: 19526325
[TBL] [Abstract][Full Text] [Related]
31. Multigene Panel Testing Provides a New Perspective on Lynch Syndrome.
Espenschied CR; LaDuca H; Li S; McFarland R; Gau CL; Hampel H
J Clin Oncol; 2017 Aug; 35(22):2568-2575. PubMed ID: 28514183
[TBL] [Abstract][Full Text] [Related]
32. Cancer-risk by family history and mismatch-repair mutation in Lynch syndrome.
Marques-de-Sá I; Castro R; Pita I; Dinis-Ribeiro M; Brandão C
Scand J Gastroenterol; 2020 Jun; 55(6):701-705. PubMed ID: 32448028
[No Abstract] [Full Text] [Related]
33. Associations of Pathogenic Variants in MLH1, MSH2, and MSH6 With Risk of Colorectal Adenomas and Tumors and With Somatic Mutations in Patients With Lynch Syndrome.
Engel C; Ahadova A; Seppälä TT; Aretz S; Bigirwamungu-Bargeman M; Bläker H; Bucksch K; Büttner R; de Vos Tot Nederveen Cappel WT; Endris V; Holinski-Feder E; Holzapfel S; Hüneburg R; Jacobs MAJM; Koornstra JJ; Langers AM; Lepistö A; Morak M; Möslein G; Peltomäki P; Pylvänäinen K; Rahner N; Renkonen-Sinisalo L; Schulmann K; Steinke-Lange V; Stenzinger A; Strassburg CP; van de Meeberg PC; van Kouwen M; van Leerdam M; Vangala DB; Vecht J; Verhulst ML; von Knebel Doeberitz M; Weitz J; Zachariae S; Loeffler M; Mecklin JP; Kloor M; Vasen HF; ;
Gastroenterology; 2020 Apr; 158(5):1326-1333. PubMed ID: 31926173
[TBL] [Abstract][Full Text] [Related]
34. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium.
Plaschke J; Engel C; Krüger S; Holinski-Feder E; Pagenstecher C; Mangold E; Moeslein G; Schulmann K; Gebert J; von Knebel Doeberitz M; Rüschoff J; Loeffler M; Schackert HK
J Clin Oncol; 2004 Nov; 22(22):4486-94. PubMed ID: 15483016
[TBL] [Abstract][Full Text] [Related]
35. Germline deletions in the EPCAM gene as a cause of Lynch syndrome - literature review.
Tutlewska K; Lubinski J; Kurzawski G
Hered Cancer Clin Pract; 2013 Aug; 11(1):9. PubMed ID: 23938213
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer.
Caldés T; Godino J; Sanchez A; Corbacho C; De la Hoya M; Lopez Asenjo J; Saez C; Sanz J; Benito M; Ramon Y Cajal S; Diaz-Rubio E
Oncol Rep; 2004 Sep; 12(3):621-9. PubMed ID: 15289847
[TBL] [Abstract][Full Text] [Related]
37. The PREMM(1,2,6) model predicts risk of MLH1, MSH2, and MSH6 germline mutations based on cancer history.
Kastrinos F; Steyerberg EW; Mercado R; Balmaña J; Holter S; Gallinger S; Siegmund KD; Church JM; Jenkins MA; Lindor NM; Thibodeau SN; Burbidge LA; Wenstrup RJ; Syngal S
Gastroenterology; 2011 Jan; 140(1):73-81. PubMed ID: 20727894
[TBL] [Abstract][Full Text] [Related]
38. Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers.
van der Post RS; Kiemeney LA; Ligtenberg MJ; Witjes JA; Hulsbergen-van de Kaa CA; Bodmer D; Schaap L; Kets CM; van Krieken JH; Hoogerbrugge N
J Med Genet; 2010 Jul; 47(7):464-70. PubMed ID: 20591884
[TBL] [Abstract][Full Text] [Related]
39. Toward a better definition of EPCAM deletions in Lynch Syndrome: Report of new variants in Italy and the associated molecular phenotype.
Cini G; Quaia M; Canzonieri V; Fornasarig M; Maestro R; Morabito A; D'Elia AV; Urso ED; Mammi I; Viel A
Mol Genet Genomic Med; 2019 May; 7(5):e587. PubMed ID: 30916491
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
